ALSO SUITABLE AS LONG-COVID THERAPY
The interval hypoxia and hyperoxia therapy is a form of oxygen therapy for the cells. Oxygen-poor air (hypoxia; irritation phase) and oxygen-rich air (hyperoxia; recovery phase) are alternately added to the body for a few minutes at a time. The term interval hypoxia-hyperoxia therapy is derived from this change.
This change between oxygen-poor and oxygen-rich air triggers biochemical processes and a chain of positive reactions in the body’s cells.
The cells and their functions are activated, followed by biochemical reactions and genetic transcription processes. The aim of IHHT is to increase the number of healthy mitochondria (cell power plants) again and to push back weak ones and thus increase the energy balance in the cells.
This in turn leads to more performance, promotion of cell metabolism and more well-being. It also leads to, for example, improved fat burning, improved blood circulation and a reduction in inflammation.
IHHT has been used successfully for many years as a method to treat a disturbed energy metabolism and, in particular, for a wide variety of chronic diseases, as the body’s self-healing processes are activated.
The procedure of interval hypoxia and hyperoxia therapy is used not only for athletes but also for chronic and degenerative indications. It promises quick pain relief and an overall beneficial effect on the healing process.
Hypoxie-Hyperoxie-Intervall-Therapy with the latest technology by CellairOne.